DUBLIN, May 12, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Orphan Drugs Market Outlook 2020" report to their offering.
Orphan drugs are medicinal products which are used for the treatment of diseases or conditions which affect a very small portion of the population. The Global Orphan Drug Market was around US$97 Billion in 2014, and is anticipated to grow to around US$181.4 Billion by 2020. It is believed that, the market will continue the trend of its incessant growth owing to factors, such as inclining healthcare expenditure, increasing prevalence of chronic diseases, short timeline required for orphan drug development. Furthermore, government incentives in the form of grants and tax credits, fees waivers and prolonged exclusivity are other major factors fueling the growth of the market.
According to the report, Global Orphan Drugs Market Outlook 2020, in the wake of the above developments the Global Orphan Drug Industry is expected to grow at a CAGR of around 11% from 2014-2020. The market has been segmented on the basis of type, geographic regions and therapeutic applications. The clinical pipeline of orphan drugs has also been provided. Various drivers and challenges have been listed down that affect the Global Orphan Drug Industry. We have also deduced a list of top five companies which are ruling this industry. These companies include the likes of Novartis, Roche, Celgene, Pfizer and Sanofi. Moreover, the report includes the revenue of top 10 orphan drugs in 2014. The trends and developments in the industry and mergers for enhanced orphan drug manufacturing capability have been highlighted. The regulatory scenario pertaining to orphan drug manufacturing and trade has also been discussed in detail. A future opportunity assessment and recommendations have been highlighted to indicate that the Global Orphan Drug Industry has a promising future.
The report also covers the key players of the Global Orphan Drug Market. For every player, a brief business overview, geographic revenue break up and segment wise revenue break up along with key financials has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Orphan Drug Market.
Some of the key findings of the report are:
- Rise in Number of Orphan Drugs for Oncology - Gene Therapy- Gaining Popularity for Rare Conditions
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Orphan Drug - An Introduction
4. Drivers and Challenges
4.1 Drivers
4.1.1 Rising Healthcare Expenditure
4.1.2 Increasing Prevalence of Chronic Diseases
4.1.3 Shorter Development Timeline & Orphan Drug Exclusivity (ODE)
4.1.4 Grants and Tax Credits
4.2 Challenges
4.2.1 High Cost of Orphan Drugs
4.2.2 Lack of Disease History Awareness & Research Participants
4.2.3 Increased Competition from Generics Industry
5. Global Orphan Drug Market - Overview
6. Market Segmentation
6.1 By Type
6.2 By Geography
6.3 By Applications
7. Current Status of Orphan Drugs in Pipeline
8. Trends and Developments
8.1 Rise in Number of Orphan Drugs for Oncology
8.2 Gene Therapy- Gaining Popularity for Rare Conditions
9. Mergers and Acquisitions
10. Regulatory Scenario
10.1 US
10.2 EU
10.3 Japan
10.4 India
10.5 China
11. Competitive Landscape
12. Key Player Analysis
12.1 Novartis
12.2 F. Hoffmann-La Roche AG
12.3 Celgene Corporation
12.4 Pfizer Inc.
12.5 Sanofi
12.6 Bristol-Myers Squibb
12.7 Johnson & Johnson
12.8 Merck & Co., Inc.
12.9 Boehringer Ingelheim GmbH
12.10 AbbVie
13. Opportunities & Recommendations
For more information visit http://www.researchandmarkets.com/research/rlxcnd/global_orphan
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
